Dr. Armando Navarro Ocaña is a Full-Time
Professor at the Faculty of Medicine, National Autonomous University of Mexico
(UNAM), with PhD in Biological Sciences from the Faculty of Medicine
at UNAM and a PhD in Medical and Biological Sciences from the Faculty of
Medicine at UABJO. For more than 15 years, he has been a Professor
of Microbiology and Parasitology and has been recognized for academic
excellence in teaching and research. Since 2004, he has led a laboratory in the
Department of Public Health at UNAM’s Faculty of Medicine, where he has built a
strong record in research, teaching, and academic mentorship. He has supervised
undergraduate and graduate theses and contributed to the training of students
through multiple National Academic Programs. His research focuses on microbial
pathogenicity, molecular epidemiology, host–pathogen interactions, intestinal
immune responses, gut microbiota, and the development of probiotic for disease
prevention. A major contribution under his leadership is the development of the
SERUNAM antisera system for E. coli and V. cholerae, which has
supported serological characterization in national and international academic
settings. This work has contributed to publications in high-impact journals,
including The Lancet, PNAS, and Microorganisms. Dr.
Navarro has published 88 peer-reviewed articles, He also is a member of the National
Academy of Medicine of Mexico and the Latin American Coalition for E. coli
Research.
Dr. Armando Navarro Ocaña is a Full-Time
Professor at the Faculty of Medicine, National Autonomous University of Mexico
(UNAM), with PhD in Biological Sciences from the Faculty of Medicine
at UNAM and a PhD in Medical and Biological Sciences from the Faculty of
Medicine at UABJO. For more than 15 years, he has been a Professor
of Microbiology and Parasitology and has been recognized for academic
excellence in teaching and research. Since 2004, he has led a laboratory in the
Department of Public Health at UNAM’s Faculty of Medicine, where he has built a
strong record in research, teaching, and academic mentorship. He has supervised
undergraduate and graduate theses and contributed to the training of students
through multiple National Academic Programs. His research focuses on microbial
pathogenicity, molecular epidemiology, host–pathogen interactions, intestinal
immune responses, gut microbiota, and the development of probiotic for disease
prevention. A major contribution under his leadership is the development of the
SERUNAM antisera system for E. coli and V. cholerae, which has
supported serological characterization in national and international academic
settings. This work has contributed to publications in high-impact journals,
including The Lancet, PNAS, and Microorganisms. Dr.
Navarro has published 88 peer-reviewed articles, He also is a member of the National
Academy of Medicine of Mexico and the Latin American Coalition for E. coli
Research.